New resources respond to evolving needs of today’s tech-savvy patients
Lexington, MA – October 24, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces the launch of the OnePath Patient Portal and Mobile Application, which will provide Shire patients who are prescribed treatments for certain rare diseases with a helpful new tool to help manage their condition and treatment.
Shire is committed to providing support to patients, caregivers, and their families. OnePath is Shire’s product support program for patients and caregivers living with certain rare diseases and specialized medical conditions.
Designed as an extension of the personalized, one-on-one product support delivered through OnePath, the new OnePath Patient Portal and Mobile Application are convenient resources to help OnePath-enrolled patients and caregivers connect with OnePath and manage their Shire treatment access.
Using these tools, patients and caregivers will be able to:
“This important milestone represents Shire’s commitment to supporting patients and families living with rare and specialized conditions,” said Dan McNamara, Head of US Patient Services at Shire. “By offering patients more options for connecting and communicating with OnePath, we have heard and are responding to the needs of our evolving patient community. I couldn’t be more proud of this new offering and the value it will bring to our patients and their families.”
Ed Kloskowski, Head of US Commercial IT at Shire, commented: "Being a leader in Rare and Specialty diseases means we recognize patients are also consumers who use technology in their daily lives. The OnePath Patient portal and mobile app gives our patients cutting-edge technology today's consumers expect and deserve.”
Shire patients and authorized caregivers can create their secure Patient Portal account at www.onepath.com or by downloading the OnePath Mobile Application. The OnePath Mobile Application is available in the iTunes App Store and Google Play Store.
|Katie Joycefirstname.lastname@example.org||+1 781 482 2779|
|Gwen Fisheremail@example.com||+1 781 482 9649|
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.